title: [Advances in intercalating drugs].
authors.affiliation: Service de Médecine Oncologique, Institut Curie, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Pouillart
authors.forename: P
authors.initials: P
authors.lastname: Beuzeboc
authors.forename: T
authors.initials: T
authors.lastname: Dorval
authors.forename: E
authors.initials: E
authors.lastname: Garcia-Giralt
authors.forename: M
authors.initials: M
authors.lastname: Jouve
authors.forename: T
authors.initials: T
authors.lastname: Palangie
authors.forename: S
authors.initials: S
authors.lastname: School
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use; D015251:Epirubicin / Q000627:therapeutic use; D006801:Humans; D007364:Intercalating Agents / Q000627:therapeutic use*; D008942:Mitoxantrone / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D007364:Intercalating Agents; D015251:Epirubicin; D004317:Doxorubicin; D008942:Mitoxantrone
vernacular_title: Progrès dans les intercalants.